News

Main Content

Stay up-to-date on the latest news from CIBMTR.

Filter Results

Skip to Results Listing clear all

Keywords

Content Types

Meetings

News

Research Updates

View Results

Please wait while we gather your results.

Results Updated, 28 Results.

Skip to Filters

In Transplantation and Cellular Therapy Journal: Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR

Review contemporary guidelines for allogeneic hematopoietic cell donor sel...

Content Types

News
Research Updates

In JCO: BMT CTN 1702 - Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation

Read about study results just published in the Journal of Clinical Oncolog...

Content Types

News
Research Updates

CIBMTR at ISOQOL 2025

Advancing patient-centered research in cellular therapy at ISOQOL 2025. Le...

Content Types

Meetings
News

CIBMTR Page Scholars Program

We welcome our newest Page Scholars and congratulate our inaugural group o...

Content Types

News

CIBMTR Reaches PRO Protocol Milestone

5,000+ patient-reported outcomes (PRO) surveys have now been collected fro...

Content Types

News

In Memory of Professor Daopei Lu, MD

We are deeply saddened by the loss of Professor Daopei Lu.

Content Types

News

New Scientific Director

Anna Huppler, MD, to serve as Scientific Director of the Infection and Imm...

Content Types

News

New Immunobiology Working Committee Co-Scientific Director

Rohtesh Mehta, MD, MPH, MS, will serve as a new co-Scientific Director of ...

Content Types

News

New GVHD Working Committee Scientific Director

Najla El Jurdi, MD, to serve as Scientific Director of Graft-versus-Host D...

Content Types

News

Wasay Khan, New Scientific Director for Clinical Informatics

Wasay Khan, MD, to serve as Scientific Director for Clinical Informatics

Content Types

News

Amy Moskop, New ACT Lead for CIBMTR

It gives us great pleasure to announce that Amy Moskop, MD, MS, has been c...

Content Types

News

Expanded Medicare Coverage for Allogeneic HCT for MDS

Content Types

News

Results of Pre-MEASURE Study By NMDP/Be The Match, CIBMTR, and the NHLBI Published in JAMA

The Pre-MEASURE study was a multicenter evaluation of the prognostic signi...

Content Types

News
Research Updates

Joint Letters Regarding Immunocompromised Patients and COVID-19 Funding

CIBMTR Celebrates 50th Anniversary During the 2022 Tandem Meetings

Content Types

Meetings
News

CIBMTR Named Recipient of 2021 Amazon Web Services Imagine Grant for Nonprofits

Content Types

News

CIBMTR Launches Study of COVID-19 Vaccine Immunogenicity in Patients With Hematological Malignancies Who Have Received Cellular Therapy

Content Types

News

Results of multicenter clinical trial sponsored by National Marrow Donor Program

Content Types

News

CIBMTR Study Shows, People Who Had BMT Have Higher Risk of Dying of COVID-19

Content Types

News

DBtC now includes CAR-T Visualizations & REMS Data

Content Types

News

CIBMTR Clinical Outcomes Registry Automates Data Collection to Accelerate Life-Saving Research

Content Types

News

CIBMTR completes enrollment in Yescarta® long-term post-marketing safety study, 2 years ahead of schedule

Content Types

News

New Leaders at ASTCT and CIBMTR Provide Guidelines for Combating COVID-19 and Protecting Transplant Patients

Content Types

News

CIBMTR® announces real-world data effort to accelerate breakthroughs that transform patient experiences in cellular therapy with IQVIA

Content Types

News

Kite and the CIBMTR® Present Positive Findings From Real-World Use of Yescarta® in Relapsed or Refractory Large B-Cell Lymphoma

Content Types

News

Gamida Cell and the CIBMTR Announce Collaboration to Advance Research for Life-Saving Cellular Therapy

Content Types

News

CIBMTR to Track Long-Term Outcomes Data for Kymriah®

Content Types

News

CIBMTR Announces Collaboration with Kite to Track Long-Term Outcomes Data for YESCARTA®

Content Types

News